Pie diagrams revealed that the high-risk group predominantly included clinical features associated with poor prognosis, such as higher grades (Grade3, Grade4), 1p/19q non-codel, unmethylated MGMT promoter, wild-type IDH status, glioblastoma histology, CL and ME Transcriptome subtype (Figures 7G–L). This evidence concerns the gene MGMT and glioblastoma.